The exact mechanism of
ethanol's effects on
glucose tolerance has not been well determined. The present study focuses for the first time on
hypoxia and low-grade
inflammation in adipose tissue (AT). In the in vivo experiments, twenty-four male Wistar rats were randomly allocated into control and
ethanol feeding groups.
Ethanol-treated rats received edible
ethanol once a day at a total dosage of 5 g/kg per d, and the controls received distilled water.
Ethanol volumes were adjusted every week. At the end of 8 weeks, we carried out an oral
glucose tolerance test. Blood and AT were collected for measuring
hypoxia-inducible factor-1α (HIF-1α), GLUT1, TNF-α,
IL-6,
leptin and
vascular endothelial growth factor (
VEGF). In the in vitro experiments, differentiated OP9 adipocytes were incubated with 100 mm of
ethanol for 48 h; the media and cells were then collected for measuring HIF-1α, GLUT1, TNF-α and
IL-6. The results showed that long-term
ethanol consumption
impaired glucose tolerance in rats.
Ethanol consumption had little influence on
body weight, but both epididymal and perirenal AT were markedly enlarged in the
ethanol-treated rats as compared to the controls. Visceral adipose tissue (VAT) had accumulated, and the
protein levels of HIF-1α and GLUT1, the indicators of
hypoxia in rat epididymal AT and OP9 adipocytes, were elevated. Secondary to the AT
hypoxia, the levels of
inflammation-related
adipokines, such as TNF-α,
IL-6,
leptin and
VEGF, were increased. Based on these findings, we conclude that VAT
hypoxia and low-grade
inflammation might be a new mechanism in the treatment of
ethanol-related diabetes.